Treating Multiple Sclerosis in a Medicaid Population

July 18, 2017

Determining the best specific disease-modifying drugs. 

Previous Flipbook
Metabolic Monitoring of Atypical Antipsychotics
Metabolic Monitoring of Atypical Antipsychotics

Next Flipbook
Acute Respiratory Distress and Opioid Morphine Equivalents
Acute Respiratory Distress and Opioid Morphine Equivalents

Finding trends in Medicaid members across 3 dose ranges.